(Updated - April 15, 2025 7:19 AM EDT)

Needham analyst Ami Fadia upgraded Neurocrine Bio. (NASDAQ: NBIX) from Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE